Sale!

EGR2 Gene Dejerine-Sottas Disease Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EGR2 Gene Dejerine-Sottas Disease Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to identify mutations in the EGR2 gene, which are linked to the development of Dejerine-Sottas Disease (DSD). DSD, also known as hereditary motor and sensory neuropathy type III, is a rare genetic disorder characterized by severe demyelination of peripheral nerves, leading to muscle weakness, sensory loss, and in some cases, deformities of the extremities.

This test plays a crucial role in the early detection and management of the disease, allowing for a tailored approach to treatment and care for affected individuals. The process involves collecting a DNA sample, typically through a blood draw, which is then analyzed for specific genetic alterations in the EGR2 gene that are associated with the condition.

At DNA Labs UAE, the EGR2 Gene Dejerine-Sottas Disease Genetic Test is priced at 4400 AED. The cost reflects the sophisticated technology and expertise required to accurately identify the genetic variations linked to this rare condition. By opting for this test, patients and their families can gain valuable insights into the genetic basis of the disease, facilitating informed decisions about management and therapy options.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EGR2 Gene Dejerine-Sottas disease Genetic Test

Are you or a loved one experiencing muscle weakness and sensory loss? It could be a sign of Dejerine-Sottas disease (DSD), a rare genetic disorder that affects the peripheral nerves. At DNA Labs UAE, we offer the EGR2 Gene Dejerine-Sottas disease Genetic Test to help diagnose and manage this condition.

Test Details

The EGR2 Gene Dejerine-Sottas disease Genetic Test is a comprehensive genetic test that utilizes NGS (Next-Generation Sequencing) technology. This powerful tool allows us to sequence the entire coding region of the EGR2 gene, which is responsible for producing a protein called early growth response 2.

By analyzing the genetic sequence, our team of experts can identify any mutations or variations in the EGR2 gene that may be causing DSD. This information is crucial for accurately diagnosing the condition and providing personalized treatment options.

Test Components and Price

The EGR2 Gene Dejerine-Sottas disease Genetic Test is priced at 4400.0 AED. The test can be conducted using either blood or extracted DNA samples. Alternatively, one drop of blood can be collected on an FTA card for testing.

Report Delivery

Once the samples are collected, the report will be delivered within 3 to 4 weeks. Our team will ensure that you receive a detailed report with all the necessary information about the genetic mutations detected.

Test Type and Department

The EGR2 Gene Dejerine-Sottas disease Genetic Test falls under the category of Neurological Disorders. Our experienced neurologists will oversee the testing process and interpret the results accurately. The test is conducted in our Genetics department, where we specialize in genetic testing and counseling.

Pre Test Information

Before undergoing the EGR2 Gene Dejerine-Sottas disease Genetic Test, it is essential to provide the clinical history of the patient. This information helps our experts understand the symptoms and medical background, enabling them to interpret the test results effectively.

Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by EGR2 Gene Dejerine-Sottas disease. This chart helps identify any patterns of inheritance and provides valuable insights for genetic counseling.

About Dejerine-Sottas Disease

Dejerine-Sottas disease (DSD) is a rare genetic disorder that primarily affects the peripheral nerves. The condition is characterized by muscle weakness and sensory loss. It is caused by mutations in the EGR2 gene, which disrupts the production of the early growth response 2 protein.

Individuals with DSD often experience difficulties with motor skills, such as walking and coordination. Sensory loss, including decreased sensitivity to touch, pain, and temperature, is also common. The severity of symptoms can vary from mild to severe.

The Importance of NGS Genetic Testing

NGS genetic testing plays a crucial role in diagnosing and managing Dejerine-Sottas disease. By analyzing the EGR2 gene, we can identify the specific genetic mutation responsible for the condition. This information not only confirms the diagnosis but also helps guide treatment decisions.

Furthermore, NGS genetic testing provides valuable insights for genetic counseling. By understanding the genetic basis of DSD, affected individuals and their families can make informed decisions about family planning and potential treatment options.

Conclusion

If you or a loved one are experiencing symptoms of Dejerine-Sottas disease, the EGR2 Gene Dejerine-Sottas disease Genetic Test offered by DNA Labs UAE can provide the answers you need. Our comprehensive NGS genetic testing approach, overseen by experienced neurologists, ensures accurate diagnosis and personalized treatment options.

Contact DNA Labs UAE today to schedule your EGR2 Gene Dejerine-Sottas disease Genetic Test and take the first step towards managing your condition.

Test Name EGR2 Gene Dejerine-Sottas disease Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EGR2 Gene Dejerine-Sottas disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene Dejerine-Sottas disease
Test Details

Dejerine-Sottas disease (DSD) is a rare genetic disorder that affects the peripheral nerves, leading to muscle weakness and sensory loss. It is caused by mutations in the EGR2 gene, which provides instructions for making a protein called early growth response 2.

NGS (Next-Generation Sequencing) genetic testing is a powerful tool that can be used to detect mutations in the EGR2 gene. This test involves sequencing the entire coding region of the gene to identify any changes or variations that may be causing DSD.

NGS genetic testing can help diagnose DSD and provide valuable information about the specific genetic mutation that is causing the disease. This information can be used to guide treatment decisions and provide genetic counseling to affected individuals and their families.

Overall, NGS genetic testing for the EGR2 gene is an important tool for the diagnosis and management of Dejerine-Sottas disease.